BVNKF
Price
$36.38
Change
+$0.03 (+0.08%)
Updated
Sep 23 closing price
Capitalization
2.79B
SILO
Price
$0.68
Change
-$0.07 (-9.33%)
Updated
Sep 30, 12:15 PM (EDT)
Capitalization
7.09M
64 days until earnings call
Interact to see
Advertisement

BVNKF vs SILO

Header iconBVNKF vs SILO Comparison
Open Charts BVNKF vs SILOBanner chart's image
Bavarian Nordic A/S
Price$36.38
Change+$0.03 (+0.08%)
Volume$248
Capitalization2.79B
Silo Pharma
Price$0.68
Change-$0.07 (-9.33%)
Volume$150
Capitalization7.09M
BVNKF vs SILO Comparison Chart in %
Loading...
BVNKF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SILO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BVNKF vs. SILO commentary
Sep 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BVNKF is a Hold and SILO is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 30, 2025
Stock price -- (BVNKF: $36.30 vs. SILO: $0.75)
Brand notoriety: BVNKF and SILO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BVNKF: 10% vs. SILO: 82%
Market capitalization -- BVNKF: $2.79B vs. SILO: $7.09M
BVNKF [@Biotechnology] is valued at $2.79B. SILO’s [@Biotechnology] market capitalization is $7.09M. The market cap for tickers in the [@Biotechnology] industry ranges from $98.9B to $0. The average market capitalization across the [@Biotechnology] industry is $1.9B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BVNKF’s FA Score shows that 0 FA rating(s) are green whileSILO’s FA Score has 0 green FA rating(s).

  • BVNKF’s FA Score: 0 green, 5 red.
  • SILO’s FA Score: 0 green, 5 red.
According to our system of comparison, BVNKF is a better buy in the long-term than SILO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BVNKF’s TA Score shows that 1 TA indicator(s) are bullish while SILO’s TA Score has 5 bullish TA indicator(s).

  • BVNKF’s TA Score: 1 bullish, 3 bearish.
  • SILO’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, SILO is a better buy in the short-term than BVNKF.

Price Growth

BVNKF (@Biotechnology) experienced а -0.14% price change this week, while SILO (@Biotechnology) price change was -4.31% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.32%. For the same industry, the average monthly price growth was +11.43%, and the average quarterly price growth was +59.67%.

Reported Earning Dates

SILO is expected to report earnings on Dec 03, 2025.

Industries' Descriptions

@Biotechnology (+2.32% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BVNKF($2.79B) has a higher market cap than SILO($7.09M). BVNKF YTD gains are higher at: 37.970 vs. SILO (-15.775). BVNKF has higher annual earnings (EBITDA): 2.12B vs. SILO (-4.88M). BVNKF has more cash in the bank: 1.66B vs. SILO (6.26M). SILO has less debt than BVNKF: SILO (18.9K) vs BVNKF (136M). BVNKF has higher revenues than SILO: BVNKF (6.46B) vs SILO (72.1K).
BVNKFSILOBVNKF / SILO
Capitalization2.79B7.09M39,298%
EBITDA2.12B-4.88M-43,396%
Gain YTD37.970-15.775-241%
P/E Ratio12.91N/A-
Revenue6.46B72.1K8,952,843%
Total Cash1.66B6.26M26,565%
Total Debt136M18.9K719,577%
FUNDAMENTALS RATINGS
BVNKF vs SILO: Fundamental Ratings
BVNKF
SILO
OUTLOOK RATING
1..100
9782
VALUATION
overvalued / fair valued / undervalued
1..100
45
Fair valued
58
Fair valued
PROFIT vs RISK RATING
1..100
92100
SMR RATING
1..100
6199
PRICE GROWTH RATING
1..100
4252
P/E GROWTH RATING
1..100
93100
SEASONALITY SCORE
1..100
8529

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BVNKF's Valuation (45) in the null industry is in the same range as SILO (58). This means that BVNKF’s stock grew similarly to SILO’s over the last 12 months.

BVNKF's Profit vs Risk Rating (92) in the null industry is in the same range as SILO (100). This means that BVNKF’s stock grew similarly to SILO’s over the last 12 months.

BVNKF's SMR Rating (61) in the null industry is somewhat better than the same rating for SILO (99). This means that BVNKF’s stock grew somewhat faster than SILO’s over the last 12 months.

BVNKF's Price Growth Rating (42) in the null industry is in the same range as SILO (52). This means that BVNKF’s stock grew similarly to SILO’s over the last 12 months.

BVNKF's P/E Growth Rating (93) in the null industry is in the same range as SILO (100). This means that BVNKF’s stock grew similarly to SILO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BVNKFSILO
RSI
ODDS (%)
Bullish Trend 1 day ago
60%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
N/A
Bullish Trend 1 day ago
88%
Momentum
ODDS (%)
Bearish Trend 1 day ago
63%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
N/A
Bullish Trend 1 day ago
84%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
59%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
55%
Bullish Trend 1 day ago
85%
Advances
ODDS (%)
N/A
Bullish Trend 8 days ago
87%
Declines
ODDS (%)
N/A
Bearish Trend 6 days ago
90%
BollingerBands
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
68%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
BVNKF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SILO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TARS58.081.79
+3.18%
Tarsus Pharmaceuticals
PMCB0.980.01
+1.03%
PharmaCyte Biotech
DPZ434.41-1.34
-0.31%
Dominos Pizza Inc
DIBS2.63-0.01
-0.38%
1stdibs.com
ARKO4.54-0.05
-1.09%
ARKO Corp

BVNKF and

Correlation & Price change

A.I.dvisor tells us that BVNKF and LABFF have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BVNKF and LABFF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BVNKF
1D Price
Change %
BVNKF100%
-0.21%
LABFF - BVNKF
24%
Poorly correlated
N/A
SILO - BVNKF
22%
Poorly correlated
-2.70%
GOVX - BVNKF
22%
Poorly correlated
-2.65%
MBXBF - BVNKF
21%
Poorly correlated
+0.17%
IMRN - BVNKF
20%
Poorly correlated
-0.74%
More